RhumbLine Advisers’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $812K | Sell |
|
|||||
|
2025
Q2 | $632K | Sell |
|
|||||
|
2025
Q1 | $556K | Buy |
|
|||||
|
2024
Q4 | $564K | Sell |
|
|||||
|
2024
Q3 | $508K | Sell |
|
|||||
|
2024
Q2 | $654K | Sell |
|
|||||
|
2024
Q1 | $827K | Sell |
|
|||||
|
2023
Q4 | $1.09M | Sell |
|
|||||
|
2023
Q3 | $890K | Sell |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $939K | Buy |
|
|||||
|
2022
Q4 | $935K | Buy |
|
|||||
|
2022
Q3 | $818K | Buy |
|
|||||
|
2022
Q2 | $678K | Buy |
|
|||||
|
2022
Q1 | $604K | Buy |
|
|||||
|
2021
Q4 | $691K | Buy |
|
|||||
|
2021
Q3 | $450K | Buy |
|
|||||
|
2021
Q2 | $848K | Sell |
|
|||||
|
2021
Q1 | $1.26M | Sell |
|
|||||
|
2020
Q4 | $1.16M | Buy |
|
|||||
|
2020
Q3 | $918K | Sell |
|
|||||
|
2020
Q2 | $1.49M | Buy |
|
|||||
|
2020
Q1 | $1.44M | Buy |
|
|||||
|
2019
Q4 | $1.5M | Buy |
|
|||||
|
2019
Q3 | $1.11M | Sell |
|
|||||
|
2019
Q2 | $932K | Buy |
|
|||||
|
2019
Q1 | $1.25M | Sell |
|
|||||
|
2018
Q4 | $1.43M | Buy |
|
|||||
|
2018
Q3 | $1.21M | Sell |
|
|||||
|
2018
Q2 | $902K | Buy |
|
|||||
|
2018
Q1 | $922K | Sell |
|
|||||
|
2017
Q4 | $1.08M | Sell |
|
|||||
|
2017
Q3 | $1.59M | Buy |
|
|||||
|
2017
Q2 | $1.82M | Buy |
|
|||||
|
2017
Q1 | $1.62M | Buy |
|
|||||
|
2016
Q4 | $1.3M | Buy |
|
|||||
|
2016
Q3 | $1.33M | Buy |
|
|||||
|
2016
Q2 | $772K | Sell |
|
|||||
|
2016
Q1 | $785K | Buy |
|
|||||
|
2015
Q4 | $566K | Buy |
|
|||||
|
2015
Q3 | $370K | Buy |
|
|||||
|
2015
Q2 | $414K | Buy |
|
|||||
|
2015
Q1 | $399K | Buy |
|
|||||
|
2014
Q4 | $301K | Buy |
|
|||||
|
2014
Q3 | $449K | Sell |
|
|||||
|
2014
Q2 | $666K | Buy |
|